This regulation establishes and adjusts fees for the examination of drug, biocide, and medical device submissions under Canadian food and drug regulations, with provisions for fee remission for small businesses and specific circumstances such as public health emergencies or existing authorizations. It also defines key terms, outlines eligibility for fee reductions, and ensures fees are adjusted annually based on inflation.